Company: INVUP
Filing Date: 2025-05-14
Form Type: 10-Q
Source: 0001641172-25-010230
Chunk: 47

Company: Investview, Inc.
Filing Date: 2025-05-14
Form: 10-Q
Item: Part I, Item 1
Chunk 47
---
,936 

    Segment income (loss) from operations 
    $4,021,102  
    $(780,230) 
    $3,240,872 

    [1]
    General and administrative costs consist mainly of professional fees, contracting services, equipment, shipping and tariffs, insurance and information technology and software.

The following table illustrates the reconciliation
of segment operating income to net income before taxes for the three months ended March 31, 2025 and 2024.

SCHEDULE
OF RECONCILIATION OF SEGMENT OPERATING INCOME TO NET INCOME BEFORE TAXES 

    March 31,  2025  
    March 31,  2024 
  
    Segment income from operations 
    $986,925  
    $3,240,872 

    Reconciling items 

    Bank interest 
     44,283  
     4,338 
  
    Event ticket sales 
     38,553  
     - 
  
    Leasing income 
     63,244  
     167,500 
  
    All other, net 
     5,583  
     3,531 

    Net income before taxes 
    $1,138,588  
    $3,416,241 

NOTE 13 – ACQUISITION

On October 11, 2024, Renu Laboratories LLC (a wholly
owned subsidiary of myLife Wellness Company which is a wholly owned subsidiary of Investview, Inc.) closed on the purchase of the business
and assets of Renu Labs, Inc. (“Seller”), along with a 100% ownership interest in Goldman’s Pharmaceuticals LLC and
a 50% ownership interest in ELRT Technologies, LLC (together known as “Renu Labs”) from Gregg Hanson. Renu Labs is a manufacturer
of proprietary and other health, beauty and wellness products. The total purchase price of Renu Labs was $1,780,000.

    28

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

The transaction was accounted for as a business combination
using the acquisition method of accounting in accordance with the ASC Topic 805. The following table summarizes the purchase accounting
for the fair value of the assets acquired and liabilities assumed at the date of the acquisition:

 SCHEDULE
OF